lets see what the independant expert report says. the deal could have been presented better though. Directors get shares in the new company while ordinary shareholders get a lousy deal
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025